News
2024-01-03
New publication: A Microfluidic High-Capacity Screening Platform for Neurological Disorders
We are happy to announce the publication of “A Microfluidic High-Capacity Screening Platform for Neurological Disorders”. In the paper, published...
News
2023-11-28
Cellectricon is looking for a scientist to join our team
Cellectricon is an innovative services provider dedicated to advancing drug discovery and research in the areas of peripheral neuropathies, neuroplasticity...
Events
November 11-15, 2023
Neuroscience 2023
The Neuroscience 2023 meeeting takes place in Washington D.C. on November 11-15. During the conference, we will present several posters...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

News
2023-10-19
Cellectricon receives CIR (French Research Tax Credit) accreditation
MÖLNDAL, SWEDEN Cellectricon AB, a services provider dedicated to advancing neuroscience drug discovery, today announced that it has received CIR...
Events
October 10-12, 2023
Neuropsychiatric Drug Development Summit
The 6th Neuropsychiatric Drug Development Summit takes place in Boston, US on October 10-12. The meeting focuses on the advancement...
Events
October 11-13, 2023
BioJapan
BioJapan takes place in Yokohama, Japan on October 11-13, 2023. The meeting is held in parallel with Regenerative Medicine JAPAN...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

News
2023-09-26
Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services
Mölndal, Sweden Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, today announced the launch of a new service...
Events
June 6-7, 2023
Discovery Europe 2023
Discovery Europe and the Neuroscience Drug Development Europe meetings take place in parallel in Berlin, Germany on June 6-7, 2023....
Events
May 15-16, 2023
Neuro4D 2023
The Neuro4D conference takes place in Mainz, Germany on May 15-16, 2023. With a focus on drug discovery for proteopathic...